|Publication number||US2979511 A|
|Publication date||Apr 11, 1961|
|Filing date||Mar 25, 1959|
|Priority date||Mar 25, 1959|
|Publication number||US 2979511 A, US 2979511A, US-A-2979511, US2979511 A, US2979511A|
|Inventors||Krapcho John, William A Lott|
|Original Assignee||Olin Mathieson|
|Export Citation||BiBTeX, EndNote, RefMan|
|Non-Patent Citations (1), Referenced by (17), Classifications (5)|
|External Links: USPTO, USPTO Assignment, Espacenet|
United States Patent f This invention relates to. new.-liet er ocyclic derivatives of benzodioxane and more p'arti'cularly to compounds .of the general formula III and acid-addition salts of those compounds which contain a basic nitrogen atom, wherein R and R are the same or different and represent hydrogen, hydroxy, halogen, trifiuoromethyl, nitro, lower alkyl, lower alkenyl or lower alkoxy; R", R'" and R"" are the s'ameor different andrepresent hydrogen or lower alkyl; x is zero or one, y is zero or one, and Z is -NH, or --N( lower alkyl). Particularly preferred are compounds wherein R, R, R",
Rf and'R"" are hydrogen, y is zero, and Z is -NH 'The compounds of this invention are physiologically active substances which are useful as peripheral vasodilators. Thus, they may be used instead of known peripheral vasodilators, such as Priscoline,'in the treatment of peripheral vascular diseases, for which purpose they are administered perorally or parenterally'with concentration and dosage adjusted for the activity of the particular compound. Furthermore, the compounds of this invention also possess adrenergic blocking and hypotensive action, and thus may be used instead of known agents such as Dibenamine in the treatment of hypertension.
The compounds of this invention are prepared by the process of this invention which comprises heating a compound of the general formula CHi I bmomncooa wherein R, R, and x are as hereinbefore defined, and
A is hydrogen or lower alkyl (preferably methyl), wit a compound of the general formula:
wherein R", R', R",' y and Z are as hereinbefore defined.
Suitable benzodioxane reactants include the following carboxylic acids, as well as the lower alkanol esters thereof: 1 ,4-benzodioxane-Z-carboxylic acid; hydroxy-1,4-benzodioxane-Z-carboxylic acids, suchas 6-hydroxy-l,4-benzodioxane-Z-carboxylic acid and 8-hydroxy-l,4-benzodioxane-Z-carboxylic acid; dihydroxy-1,4-benzodioxane-2 carboxylic acid, 8-ethyl-1,4-benzodioxane-2-carboxylic acid, and 7-n-propyl-1,4-benzodioxane-Zcarboxylic acid; di-(lower alkyl)-1,4-benz0dioxane 2 carboxylic acids, such as 6,8-dimethyl-1,4-benzodioxane-Z-carboxylic acid and 7,8-diethyl-1,4 benzodioxane-Z-carboxylic acid; lower alkoxy-l,4-benzodioxane-2-carboxylic acids, such as 6- methoxy-1,4-benzodioxane-2-carboxylic. acid and 8-ethoxy-1,4-benzodioxane-Z-carboxylic acid; di(lower a1koxy)- l,4-benzodioxane-Z-carboxylic acids; lower alkyl-lower alkoxy-1,4-benzodioxane-Z-carbdxylic acids, such as 6- methyl- 8-ethoxyl,4 benzodioxane 2 carboxylic acid;
'- (lower alkenyl)-1,4-benzodioxane-2carboxylic acid, such as 6-allyl-1,4-benzodioxane-Z-carboxylic acid; 1,4-benzo-" dioxane-Z-acetic acid;fand-, the'hydroxy, halo, trifluor'omethyl, nitro, lower alkyl, loweralkenyl, and lower alkoxy derivatives of the last. 7 V
In those cases where the l,4-benzodioxane-2-carboxylic acids (and the corresponding lower alkyl esters) are new compounds, they can be prepared by reacting a pyrocatechol of the formula wherein R and R' are as hereinbefore defined, with a dibromoalkanoic acid ester of the formula:
wherein x is as hereinbefore defined, and if desired hy-. drolyzing the resultant ester to the corresponding acid. Those compounds wherein x is one can also be obtained from the corresponding l,4-benzodioxane-2-carboxylic acid derivative by a series of steps including: (1) treating the acid with lithium aluminum hydride to yield the corresponding carbinol derivative; (2) reacting the carbinol with thionyl chloride in pyridine to yield the corresponding methyl chloride derivative; (3) reacting the methyl chloride derivative with sodium cyanide to yield the cor-f responding methyl nitrile derivative; and (4) hydrolyzing the nitrile to a carboxyl radical, thereby covering the original carboxylic acid radical to an acetic acid radical. (The pyrocatechols can be obtained by reduction ofv the correspondingly substituted o-nitrophenol to the o-aminophenol, followed by diazotization to the pyrocatechols.)
Suitable amine reactants include lower alkylene di amines, such as ethylene diamine, trimethylene diamine,
isopropylene diamine, 2,3-butylene diamine, 2,4-pentylene diamine, 2,3-hexylene diamine, and 2,4-octylene diamine; and N-(lower alkyl)-lower alkylene diamines, such as N-(lower alkyl)-ethylenediamines (e.g. N-ethyl-ethylenediamine), N-(lower alkyl)-trimethylene diamines (e.g. N-methyl-1,3-propanediamine), and N-(lower alkyl)-isopropylene diamines.
The compound formed, if it contains a basic nitrogen atom, can then be converted to its acid addition salt in the usual manner by treatment with the desired acid. The preferred acids are those which are non-toxic and include inorganic acids, such as the hydrohalic acids (e.g. hydrochloric acid), sulfuric acid, phosphoric acid, and nitric acid; and organic acids, such as tartaric acid, citric acid, oxalic acid, acetic acid, succinic acid, maleic acid and lactic aid. v a
The following examples illustrate the invention (all temperatures being in centigrade):
EXAMPLE 1 2- [2-(1,4-benz0dioxanyl) ]-2-imidaz0line hydrochloride (a) Preparation of 2-[2-(1,4-benzodioxanyl)]-2-imidazoline.-A mixture of 25.0 g. of 1,4-benzodioxane-2-f carboxylic acid and 40 g. of ethylenediamine is refluxed" for sixteen hours. At this point, about 10 ml. of-distils on trituration with aeetonitrile to a crystalline material;
melting at about 235-240 dem). After recrystallization from isopropyl alcohol, the colorless hydrochloride salt melts at about 241-243 (deg),
EXAMPLE 2 Following the procedure of Example 1, step (a) but substituting 27.0 g. of methyl 1,4-benzodioxane-2-carboxylate for the l,4-benzodioxane-Z-carboxylic acid, the same product is obtained.
EXAMPLE 3 2-[2-(8-eth0xy-1,4-benzodioxanyl)]-2-imidaz0line oxalate- Following the procedureof Example 1, step (a) but substituting 25 g. of 8-ethoxy-1,4-benzodioxane-2-carboxylic acid, for the 1,4-benzodioxane-2-carboxylic acid, there is obtained 2-[2 (8-ethoxy l,4-benzodioxanyl)1-2- imidazoline, which upon treatment with an alcoholic solution of oxalic acid by the procedure of Example 1, step (b) yields the oxalate salt.
EXAMPLE 4 2'-['2-(l,4-benzodioxanyl) ]-1-methyl-1,4,5,6-tetra hydropyrimidine hydrochloride Following the procedure of Example 1, but substituting 50 g. of N-rnethyl-1,3-propanediamine for the ethylene diamine in step (a), there is obtained 2-[2-(1,4- benzodioxanyl)]-l-methyl 1,4,5,6-tetrahydropyrimidine hydrochloride.
EXAMPLE 5 2'-[2-(I,4-benzodioxanyl)-methyl]-2-imidazoline hydrochloride Following the procedure of Example 1, but suhstitut-. ing 26 g. of 1,4-benzodioxane-2-acetic acid for the, 1,4-
benzodioxane-2-carboxylic acid, there is obtained 2 -[2 1 ,4-benzodioxanyl methyl] -2-imidazoline hydrochloride.
EXAMPLE 6 2- 2-(7-chl0r0-1,4-benzodioxanyl) ]-2-imidaz0line Interaction of 30 g. of 7-chloro-l,4-benzodi0xane-2- carboxylic acid (prepared by reacting 4-chloropyrocatechol with ethyl u,[3-clibromopropionate) with ethylenediamine in the same manner as Example 1, step (a) gives 2-[Z-(7-ch1oro-1,4-benzodioxanyl) -2-imidazoline.
EXAMPLE 7 2- ['2-(6-trifluor0methyl-1,4-benzodi0xanyl) Z-imidazoline -I r 1 ter action of 28 g. of 6-tr ifl uoromethyl-1,4-benzodioxane-Z-carboxylic acid with ethylenediamine in the same manner as Example 1, step (a) gives 2-[2-(6-trifluoromethyl-l ,4-benzodioxanyl) 1 -2-imidazoline.
EXAMPLE 8 2-[2-(6 allyl-1,4-benz0di0xanyl) ]-2-imidaz0line Interaction of 30 g. of- 6-allyl-1,4-benzodioxane-2 carboxylic acid with ethylenediamine in thesame manner as Example 1, step (a) gives 2-[2 -(6-allyl-1,4-benzodiox-- ant 1 -2-imidazo1ine.
4 EXAMPLE. 9 2-[2-(7-nitro-1,4-benzodioxanyl) ]-2-imidazoline Interaction of 25 g. of 7-nitm-1,4-benzodioxane-2-carboxylic acid, with ethylenediamine, in, the samemanner as Example 1, step. (a) gives 2-[2;('Z-nitro-1,4-benzodioxanyl) ]-2-imidazoline.
I EXAMPLE '10 2-[2.-('l butyl l,4-benzodioxanyl)1-2-imidazoline Interaction of 25 g. of 7-butyl-1,4-benzodioxane-2-carboxylic acid with ethylenediamine in the same manner as Example 1, step (a gives 2-[2- (7-butyl-l,4-benzodioxanyl) ]-2-imidazoline.
The invention may be variously otherwise embodied within the scope of the appended claims.
What is claimed is:
1. A compound selected from the group consisting of bases of the general formula and the non-toxic acid addition salts thereof, wherein R and R are each selected .from the group consisting of hydrogen, hyroxy, .halogen, trifluoromethyl, nitro, lower alkyl, lower alkenyl and lower, alkoxy', R", R" and R' are each selectedfrom the group consisting ofhydrogen and; lower alkyl, x is an integer from zero to one, y is, an
integer from zero to one, and Z is selected from the group consisting of NH- and N'(lower alkyl-)--.
2. 2- E 2-( l,4-b enzodioxanyl) -2-imidazoline.
3. A non-toxic acid addition: salts of 2-[2-(1,4-benzodioxanyl) ]'-2-imidazoline.
4. 2[-2-(1,4-benzodioxanyl)] 2-imidazoline hydrochloride.
5. A process for preparing a compound of the general formula wherein R and R' are each selected from the group consisting of hydrogen, hydroxy, halogen, trifluoromethyl, nitro, lower alkyl, lower alkenyl, and lower alkoxy, R, R and R"" are each selected from the group consisting of hydrogen, and lower alkyl, x is an integer from zero to one, y is an integer from zero tome, and Z is. se-
lected from the group consisting of -NH-- and.
--N(lower alkyl)--, which comprises heating a compound of the general formula H(oH, r-o00A wherein R, R and x are asabove defined and A is selected from the group consisting of hydrogen and lower alkyl, with acompound ofthe general formula:
H N-CHR-.-'( CHR" CHR' -ZH whereinR", R', R"", y and Z. are as above defined.
'6'. A process for preparing 2-[2-(l,4-benzodioxanyl)]- Z-imidazoline which comprises heating 1,4-benzodioxane- 2-carboxylic acid with ethylenediamine.
References-Cited in. the file. of this patent- Koo-et aLrJ'. Am. Chem. Soc., vol. 77, pages 5373-4: 619559 v.
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US3438995 *||Jan 8, 1968||Apr 15, 1969||Melville Sahyun||Diazaheterocyclic substituted benz-oxaheterocyclic compounds|
|US4302469 *||Sep 10, 1980||Nov 24, 1981||Syntex (U.S.A.) Inc.||2-(1,4-Benzodioxan-2-ylalkyl)imidazoles useful as antidepressants|
|US4397860 *||Jan 18, 1982||Aug 9, 1983||Reckitt & Colman Products Limited||Benzodioxanyl imidazoline compounds, compositions and use|
|US4402967 *||Apr 23, 1981||Sep 6, 1983||Syntex (U.S.A.) Inc.||Method for lowering intraocular pressure|
|US4405622 *||Oct 16, 1980||Sep 20, 1983||Syntex (U.S.A.) Inc.||[1-(1,4-Benzodioxan-2-yl)-4-(4-aminopyrimidin-2-yl]piperazines useful as anti-depressants|
|US4446148 *||Mar 29, 1983||May 1, 1984||Reckitt & Colman Products Limited||Benzodioxanyl imidazoline compounds, compositions and use|
|US4497818 *||Aug 5, 1981||Feb 5, 1985||Syntex (U.S.A.) Inc.||2-(1,4-Benzodioxan-2-ylalkyl)imidazoles useful as antihypertensives and platelet aggregation inhibitors|
|US4818764 *||Feb 2, 1981||Apr 4, 1989||Reckitt & Colman Products Limited||Imidazoline derivative and method of treating depression therewith|
|EP0033655A2 *||Feb 2, 1981||Aug 12, 1981||Reckitt And Colman Products Limited||Imidazoline derivative, its salts, process for preparation and pharmaceutical compositions thereof|
|EP0033655A3 *||Feb 2, 1981||Nov 25, 1981||Reckitt And Colman Products Limited||Imidazoline derivative, its salts, process for preparation, pharmaceutical compositions and therapeutic use, thereof|
|EP0058006A1 *||Jan 25, 1982||Aug 18, 1982||Reckitt And Colman Products Limited||Imidazoline derivatives, process for the preparation thereof, pharmaceutical compositions containing them and their use|
|EP0074711A2 *||Aug 2, 1982||Mar 23, 1983||Syntex (U.S.A.) Inc.||Benzodioxane-imidazoline compounds, their preparation and use|
|EP0074711A3 *||Aug 2, 1982||Apr 27, 1983||Syntex (U.S.A.) Inc.||Benzodioxane-imidazoline compounds, their preparation and use|
|EP0138358A1 *||Aug 31, 1984||Apr 24, 1985||Farmos-Yhtyma Oy||The preparation and use of 2-[2-(1,4-benzodioxanyl)]-2-imidazoline in therapy|
|EP0838217A2||Jan 23, 1997||Apr 29, 1998||Sanofi||Cosmetic composition containing neuropeptide Y receptor antagonist|
|WO1983004025A1 *||May 18, 1983||Nov 24, 1983||Institut National De La Sante Et De La Recharche M||Optical isomers of (benzodioxane-1,4 yl-2)-2delta-2 imidazoline, preparation and therapeutical application thereof|
|WO1989001774A1 *||Sep 1, 1988||Mar 9, 1989||Saad Al Damluji||Pharmaceutical compositions|
|U.S. Classification||548/311.7, 544/333|